Nilotinib (EBC-11364)
Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
641571-11-1
Purity
95%
An intermediate of nilotinib preparation. It also has agonistic effect on Gal4-TLX (Nuclear receptor subfamily 2 group E member 1/Regulatory protein GAL4), EC50 = 20 μM.
Properties
Name
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline
Smiles
CC1=CN(C=N1)C=2C=C(N)C=C(C2)C(F)(F)F
Targets
Please log in to see this information
The impurity for drugs
3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine | 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenylamine | 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl)aniline | 3-(4-methyl-1H-imidazolyl)-5-trifluoromethylaniline | 3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)aniline | 5-trifluoromethyl-3-[4-methyl-1H-imidazolyl]aniline | Nilotinib Related Compound A | Nilotinib impurity A CRS
No data available
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
Get a quoteQuantity
1
Total amount
$ 19
This compound is considered a Dangerous good for shipping. Our team will contact you with details on lead time and costs
3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine | 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenylamine | 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl)aniline | 3-(4-methyl-1H-imidazolyl)-5-trifluoromethylaniline | 3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)aniline | 5-trifluoromethyl-3-[4-methyl-1H-imidazolyl]aniline | Nilotinib Related Compound A | Nilotinib impurity A CRS
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
The compound has purity validated by NMR and/or LCMS methods.